KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Deferred Revenue (2016 - 2025)

Evolent Health has reported Current Deferred Revenue over the past 11 years, most recently at $1.2 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $1.2 million for Q4 2025, down 52.01% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (down 52.01% YoY), and the annual figure for FY2025 was $1.2 million, down 52.01%.
  • Current Deferred Revenue for Q4 2025 was $1.2 million at Evolent Health, down from $1.9 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for EVH hit a ceiling of $18.1 million in Q2 2021 and a floor of $1.2 million in Q4 2025.
  • Median Current Deferred Revenue over the past 5 years was $6.5 million (2023), compared with a mean of $7.4 million.
  • Biggest five-year swings in Current Deferred Revenue: grew 24.16% in 2023 and later tumbled 64.93% in 2024.
  • Evolent Health's Current Deferred Revenue stood at $11.9 million in 2021, then crashed by 51.79% to $5.8 million in 2022, then increased by 24.16% to $7.1 million in 2023, then tumbled by 64.93% to $2.5 million in 2024, then crashed by 52.01% to $1.2 million in 2025.
  • The last three reported values for Current Deferred Revenue were $1.2 million (Q4 2025), $1.9 million (Q3 2025), and $2.7 million (Q2 2025) per Business Quant data.